Insulin allergy and resistance successfully treated by desensitisation with Aspart insulin
Open Access
- 23 December 2005
- journal article
- case report
- Published by Springer Nature in Clinical and Molecular Allergy
- Vol. 3 (1) , 16
- https://doi.org/10.1186/1476-7961-3-16
Abstract
A 25-year-old, with type I Diabetes Mellitus with a previous diagnosis of Protamine Allergy but not to human Insulin, started to notice anaphylactic reactions inmmediatly after bolus with Insulin. Skin prick and intradermal test were positive to all insulins. Skin tests to other potential allergens resulted negative. Examination after bolus of Human Insulin revealed urticaria. Daily insulin requirement were around 2-2,4 U/Kg/day. Slow desensitisation with Aspart insulin, the insulin with lowest size of skin test, was performed using subcutaneous insulin pump. Six months after the end of desensitisation his daily insulin requirement decreased to 0.8 U/Kg/day and oral corticosteroids are being reduced with no symptoms.Keywords
This publication has 33 references indexed in Scilit:
- Successful Treatment of Insulin Allergy in a 1-Year-Old Infant With Neonatal Diabetes by Lispro and Glargine InsulinDiabetes Care, 2005
- A rational clinical approach to suspected insulin allergy: status after five years and 22 casesDiabetic Medicine, 2004
- Allergy to human insulinAllergy, 2003
- Insulin-Injection-Site Reactions Associated with Type I Latex AllergyNew England Journal of Medicine, 2003
- Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old childAnnals of Allergy, Asthma & Immunology, 2000
- Protamine allergy as a complication of insulin hypersensitivity: A case reportJournal of Allergy and Clinical Immunology, 1999
- Cutaneous allergy to human (recombinant DNA) insulinAllergy, 1998
- Severe Antibody-Mediated Human Insulin Resistance: Successful Treatment With the Insulin Analog Lispro: A case reportDiabetes Care, 1997
- Immunogenicity and Allergenic Potential of Animal and Human InsulinsDiabetes Care, 1993
- Prolonged Desensitization Required for Treatment of Generalized Allergy to Human InsulinDiabetes Care, 1993